Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04148404
Other study ID # Hypothermic vs normothermic
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2019
Est. completion date June 9, 2019

Study information

Verified date October 2019
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

On-pump CABG surgery deleteriously affects hematological and coagulation profiles of patients and this effect was accentuated by the use of cold bypass. PO altered platelet may count and function and prolonged clotting times correlates with amount of daily PO blood wound drainage and number of blood products units used, but prolonged aPTT is the best predictor for these events.


Description:

Background: The use of cardiopulmonary bypass during cardiac surgery negatively affects the coagulation system. Hypothermia is also known to inhibit the coagulation profile. The aim of the study is to assess and compare the early postoperative (PO) haematological and coagulation profile of patients undergoing coronary artery bypass graft (CABG) surgery with Hypothermic (HT) versus normothermic (NT) bypass Methods: eighty-six patients were divided into two equal groups: NT group included patients received warm bypass and using warm blood cardioplegia from bypass and HT group included patients received cold bypass and using cold cardioplegia given by the anaesthesiologist. PO monitoring included the activated clotting time (ACT) prior to wound closure and 2-hr changes in the haemoglobin concentration (Hb), platelet count (PC), ADP-induced platelet aggregation (IPA), INR in relation to preoperative profile and amount of PO daily blood loss and number of transfused blood units. The primary outcome was the PO alternations in the coagulation and haematological profile. The secondary outcome was the amount of PO daily bleeding, number of transfused blood units and incidence of re-opening surgery due to bleeding.


Recruitment information / eligibility

Status Completed
Enrollment 86
Est. completion date June 9, 2019
Est. primary completion date June 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 65 Years
Eligibility Inclusion Criteria:

1. Ischemic heart disease patients

2. Both genders

3. Aged 50 - 65 years

4. Assigned for first-time, elective and isolated on-pump CABG surgery.

Exclusion Criteria:

1. Pre-existing coagulopathy

2. Hemostasis disorders,

3. Anemia,

4. Redo or emergency CABG, re-exploration for surgical-cause PO bleeding, other associated pathologies, hepatic or renal impairment and/or maintenance on antiplatelet therapy during the last 10 days prior to surgery

Study Design


Related Conditions & MeSH terms

  • CABG Surgery, Cold Blood Cardioplegia, Coagulation Profile and Platelet Function
  • Hypothermia

Intervention

Procedure:
Normothermic group
Normothermic group (NT group) included patients will undergo CABG under warm bypass using warm blood cardioplegia (Normothermic CBP). Hypothermic group (HT group) included patients will undergo CABG under cold bypass using cold blood cardioplegia (Hypothermic CBP).

Locations

Country Name City State
Egypt Ahmed Abdalla Mohamed Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative alternations in the coagulation and haematological profile Postoperative alternations in the coagulation and haematological profile One day Postoperative
Secondary Amount of PO daily bleeding Amount of PO daily bleeding One day Postoperative
Secondary Number of transfused blood units Number of transfused blood units One day Postoperative
Secondary Incidence of re-opening surgery due to bleeding Incidence of re-opening surgery due to bleeding 24 hours Postoperative